DOD: 70 Imported Items Could Lose Exemptions to Boost Domestic Production

DOD: 70 Imported Items Could Lose Exemptions to Boost Domestic Production

The Department of Defense put out a proposed rule that is available for comment until 12/23/2024 amending the list of domestically nonavailable articles under Buy American. Federal contractors are often subject to Buy American rules that require a certain percentage of the materials they use be US-origin. There is a list of items that don't have domestic production, allowing the contractors to still be in compliance if they purchase those materials from foreign manufacturers. This rule is put out by DoD, the General Services Administration, and NASA. They're looking to take 70 of the 109 articles on that list off of the list, and to amend the process for putting articles on the list. They're proposing this as a "general reset" of the list as a means of encouraging market research and telling the domestic industry to start producing.

Read More

Related Posts

NMFS: Upcoming Import Prohibitions and Industry Webinars

The National Marine Fisheries Service (NMFS) announces that, effective January 1, 2026, imports of specific fish and fish products from countries whose fisheries have not received comparability findings under the Marine Mammal Protection Act (MMPA) will be restricted from entering the United States. To help industry prepare for these changes, NMFS will host two informational…

CBP: Settlement Reached in Aluminum Extrusions Duty Evasion Case

Harman International Industries, parent company of Harman Kardon®, JBL®, and Mark Levinson®-has agreed to pay $11,809,628 to settle allegations that it evaded antidumping and countervailing duties (ADCVD) on aluminum-extrusion heatsinks imported from China. According to the allegations, the company failed for more than a decade to disclose or correct the violations and actively concealed the…

USTR: U.S. and U.K. Reach Agreement on Pharmaceuticals and Medical Technology

On December 1, 2025, the United States and United Kingdom announced a new agreement on pharmaceuticals, pharmaceutical ingredients, and medical technology. Under this arrangement, the U.S. would remove Section 232 tariffs on U.K.-sourced medical goods, pause any Section 301 investigations related to U.K. pharmaceutical pricing during President Trump’s term, and collaborate to expand U.K. patient…

FDA: Agency Deploys Agentic AI Capabilities for Staff Use

The U.S. Food and Drug Administration announced the rollout of agency-wide agentic AI tools designed to support employees with complex, multi-step tasks. These systems build on the FDA’s earlier deployment of its LLM-based tool, Elsa-currently used voluntarily by a majority of staff-and introduce more advanced features for workflow automation, planning, and reasoning. Participation remains optional,…